Data / Drug companies / Oxycodone hydrochloride
Oxycodone hydrochloride: 36 companies and 133 products in the FDA NDC directory
Oxycodone hydrochloride is listed in the FDA National Drug Code Directory by 36 companies, with 133 products in commercial distribution. 115 of the products (86.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution; tablet, film coated, extended release, and the newest product started marketing on August 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 36
- Products
- 133
- Generic (ANDA) products
- 115 (86.5%)
- Application numbers
- 28
- Controlled substance schedule
- Schedule II
- Routes
- Oral
- Brand names
- OxyContin, RoxyBond, Oxaydo, Roxicodone
- openFDA record search
- api.fda.gov
Companies that list oxycodone hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Asclemed USA, Inc. | 13 | tablet | Generic drugs (ANDA) | September 10, 2024 |
| Bryant Ranch Prepack | 8 | tablet | Generic drugs (ANDA) | September 10, 2024 |
| KVK-Tech, Inc. | 8 | tablet; solution | Generic drugs (ANDA) | July 21, 2017 |
| Knoa Pharma LLC | 7 | tablet, film coated, extended release | New drug applications (NDA) | August 8, 2010 |
| SpecGx LLC | 7 | tablet; solution | Generic drugs (ANDA) | October 12, 2021 |
| Lupin Pharmaceuticals,Inc. | 6 | tablet; solution | Generic drugs (ANDA) | June 12, 2017 |
| St. Mary's Medical Park Pharmacy | 6 | tablet | Generic drugs (ANDA) | August 6, 2026 |
| Bryant Ranch Prepack | 5 | tablet; solution | Generic drugs (ANDA) | March 1, 2019 |
| Bryant Ranch Prepack | 5 | tablet; solution | Generic drugs (ANDA) | October 13, 2015 |
| Camber Pharmaceuticals, Inc. | 5 | tablet | Generic drugs (ANDA) | November 14, 2025 |
| Epic Pharma, LLC | 5 | tablet | Generic drugs (ANDA) | September 22, 2015 |
| Rhodes Pharmaceuticals LLC | 5 | tablet | Generic drugs (ANDA) | September 8, 2014 |
| Strides Pharma Science Limited | 5 | tablet | Generic drugs (ANDA) | September 10, 2024 |
| American Health Packaging | 4 | tablet | Generic drugs (ANDA) | February 25, 2020 |
| Protega Pharmaceuticals Inc | 4 | tablet, coated | New drug applications (NDA) | April 20, 2017 |
| Redpharm Drug | 4 | tablet; solution | Generic drugs (ANDA) | September 10, 2024 |
| Alvogen Inc. | 3 | tablet | Generic drugs (ANDA) | December 30, 2011 |
| Aurolife Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | July 12, 2012 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet | Generic drugs (ANDA) | September 8, 2014 |
| Ani Pharmaceuticals, Inc. | 2 | capsule; solution | Generic drugs (ANDA) | June 10, 2016 |
| Ascent Pharmaceuticals, Inc. | 2 | solution | Generic drugs (ANDA) | July 13, 2017 |
| Direct_Rx | 2 | tablet | Generic drugs (ANDA) | June 15, 2020 |
| Eywa Pharma Inc | 2 | solution | Generic drugs (ANDA) | March 1, 2019 |
| Major Pharmaceuticals | 2 | solution | Generic drugs (ANDA) | November 23, 2016 |
| Pai Holdings, LLC DBA Pai Pharma | 2 | solution | Generic drugs (ANDA) | April 8, 2019 |
| Quagen Pharmaceuticals LLC | 2 | solution | Generic drugs (ANDA) | June 2, 2021 |
| SpecGx LLC | 2 | tablet | New drug applications (NDA) | August 31, 2000 |
| XLCare Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | February 25, 2020 |
| Zyla Life Sciences US LLC | 2 | tablet | New drug applications (NDA) | September 1, 2015 |
| American Health Packaging | 1 | solution | Generic drugs (ANDA) | April 22, 2019 |
| Amneal Pharmaceuticals of New York LLC | 1 | tablet, film coated, extended release | Authorized generics (NDA) | February 22, 2016 |
| Genus Lifesciences | 1 | solution | New drug applications (NDA) | September 9, 2013 |
| Hikma Pharmaceuticals USA Inc. | 1 | solution | Generic drugs (ANDA) | September 4, 2014 |
| Novel Laboratories, Inc. | 1 | capsule | Generic drugs (ANDA) | August 24, 2015 |
| Precision Dose, Inc. | 1 | tablet | Generic drugs (ANDA) | December 21, 2016 |
| Quality Care Products, LLC | 1 | tablet | Generic drugs (ANDA) | October 18, 2013 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 95 | 71.4% |
| Solution | 23 | 17.3% |
| Tablet, film coated, extended release | 8 | 6% |
| Tablet, coated | 4 | 3% |
| Capsule | 3 | 2.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 115 | 86.5% |
| New drug applications (NDA) | 17 | 12.8% |
| Authorized generics (NDA) | 1 | 0.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Opioid Agonist | 133 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.